Cargando…
Bone marrow cell therapy in cardiovascular disease drives us slowly to a better identification of the active cell component
Endothelial progenitor cell therapy and stem cell therapy have been proposed in regeneration of acute myocardial infarction (AMI). In the previous issue of Stem Cell Research & Therapy, Lamirault and colleagues described a strong analysis of progenitors in blood and bone marrow of patients colle...
Autor principal: | Smadja, David M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055008/ https://www.ncbi.nlm.nih.gov/pubmed/24468573 http://dx.doi.org/10.1186/scrt405 |
Ejemplares similares
-
Does immune destruction drive all forms of bone marrow failure?
por: Dulmovits, Brian M., et al.
Publicado: (2022) -
Ex vivo manipulation of bone marrow cells to rescue uremia-induced dysfunction for autologous therapy
por: Grange, Cristina, et al.
Publicado: (2015) -
Slowly, slowly in the wind /
por: Highsmith, Patricia, 1921-1995
Publicado: (1981) -
Mesenchymal stem cells immunosuppressive properties: is it specific to bone marrow-derived cells?
por: Jorgensen, Christian
Publicado: (2010) -
Slowly Delivered Icariin/Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells to Promote the Healing of Calvarial Critical-Size Bone Defects
por: Liu, Tianlin, et al.
Publicado: (2016)